Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
EMS
480 participants
Oct 8, 2024
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to evaluate the efficacy and safety of Piemonte association in the treatment of type 2 diabetes mellitus
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Piemonte association 1 coated tablet once a day
Placebo of Piemonte association 1 coated tablet once a day
Empagliflozin 25 mg 1 coated tablet once a day
Placebo of empagliflozin 25 mg 1 coated tablet once a day
Pioglitazone 30 mg 1 tablet once a day
Placebo of pioglitazone 30 mg 1 tablet once a day
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05028140